Roche, Rona Therapeutics in $1.16-Bn RNAi Obesity Drug Deal 
By

By
Roche and Rona Therapeutics, a Santa Barbara, California-based clinical-stage bio/pharmaceutical company specializing in RNAi therapeutics, have entered an agreement under which Roche has been granted an exclusive worldwide license for…

Bausch + Lomb CEO Brent Saunders Steps Down; Interim CEO Named 
By

By
Bausch + Lomb Corporation has announced that Brent Saunders, who has served as the Chief Executive Officer (CEO) of Bausch + Lomb, the eye-health subsidiary of Bausch Health, a specialty…

Supplier News: Kindeva, Evotec, RoslinCT & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Kindeva, Evotec, CurTec, Kaleo, RoslinCT, and CellFiber.   Biologics Manufacturing * RoslinCT Receives Grant to Expand Digital Cell Therapy Operations * CellFiber Launches New Subsidiary…

Global Briefs: UCB, Gilead, AstraZeneca, Pfizer & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring UCB, Gilead, AstraZeneca, Pfizer, Galderma and Zealand Pharma. Highlights below.   For the latest news roundup on small and…

Biotech Briefs: OrbiMed, Verastem, City Therapeutics & Iambic 
By

By
The latest from small and Emerging Pharma companies featuring OrbiMed, Verastem, City Therapeutics and Iambic.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * OrbiMed Raises…

BD Announces $19 Bn in US Investments, Including $3 Bn in Mfg  
By

By
BD (Becton, Dickinson and Company), a medical technology company, has announced a partnership with the US government under which the company has agreed to invest $19 billion in the US…

Bayer To Invest $2.2 Bn in New US Mfg Site 
By

By
Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio.   The modular campus is designed to combine drug-substance and drug-product manufacturing, use…

AstraZeneca Opens New $1-Bn US R&D Center 
By

By
AstraZeneca has announced the opening of a new $1-billion global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The center is part of the company’s previously announced…

US Gov’t, Meta, Google & Biohub Investing $1.8 Billion in AI-Enabled Biology 
By

By
Biohub, a nonprofit research institute combining AI and biology, the US Department of Energy (DoE), the National Institutes of Health (NIH), and new funding partners, Google DeepMind (an AI research…

Supplier News: BASF, Evonik Flamma, Curia, Hovione & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring BASF, Evonik, Flamma, Curia, Hovione, Catalent,  Repligen, Piramal Pharma Solutions, Agilent Technologies, Thermo Fisher Scientific, Evotec, Sterling Pharma Solutions, Ofichem, Ritedose Corporation,…